When: Close below $390 on expanding volume

Then: Defensive trim or hedge deployment

HOLD - maintain neutral weight, no addition until confirmation at $414.83

• ATR is $10.26; proposed stop at $390 is less than 1 ATR from entry, requiring buffer of 1-1.5 ATR (target $379-$380)
• Free cash flow TTM is $24.3B; stock remains 15% below 52-week high despite buyback halt
• Forward P/E of 17.56 anchored to forward EPS estimate of $22.44; Q1 2026 EPS was $6.90, Q4 2025 was $0.01
• Beta of 0.632 reflects historical behavior, not current idiosyncratic risk profile
• 50 SMA resistance level at $414.83; current price below 50 SMA, 10 EMA, with confirmed bearish MACD
• No bullish divergence on RSI; MACD bearish crossover is widening
• Q3 earnings expected mid-October as key confirmation catalyst
• Change Healthcare lawsuit alleges UNH misled investors, shuttered internal Medicare billing audit, and ignored cybersecurity lapses
• Federal murder trial hasn't started; perpetrator pleaded guilty in federal court
• Conservative trim trigger: close below $390 on expanding volume, earlier than trader's thesis-breaking level

→ vs aggressive: Lower Bollinger Band 'gift' framing is dangerous; 'walking the lower band can persist' in trending markets with confirmed bearish signals

→ vs aggressive: Proposed $390 stop is 'functionally meaningless' — less than 1 ATR from entry means routine volatility will trigger stop before thesis plays out

→ vs aggressive: Change Healthcare lawsuit and murder trial are not 'tail risk' or 'headline noise' — direct attack on disclosure, governance, and brand with D&O/securities litigation tail

→ vs aggressive: 'Capital discipline, not capital distress' framing rejected; $24.3B FCF with halted buybacks and continued dividend raises signals cash preservation over equity return

→ vs aggressive: Forward P/E compression assumes $22.44 EPS plays out; only one clean quarter (Q1 $6.90) versus Q4 2025 disaster ($0.01) makes this estimate unconfirmed

→ vs aggressive: UNH is not a 'clean defensive compounder' — idiosyncratic event risk overrides sector rotation tailwind; beta of 0.632 reflects history not current risk

→ vs aggressive: Front-running trader's confirmation triggers is 'a bet against confirmation dressed up in the language of opportunity' — good trades remain good at $414.83 after confirmation

HOLD existing position; allow 25% tactical add at current levels with stop at $378-$380; consider protective puts or collars to hedge binary catalysts; maintain neutral overall weight; use $414.83 close with positive MACD as confirmation to add more, not as only entry point.

• Forward EPS of $22.44 is anchored to one clean quarter of data (Q1 2026 at $6.90 annualizes to ~$27, but Q4 2025 was effectively zero), creating uncertainty in the multiple
• Existing position stop at $390 is correct for that decision, but $390 stop on new capital at $390-$394 entry is functionally no stop at all given ATR of $10.26
• Small tactical add of ~25% of normal position size with stop at $378-$380 provides ~1.5 ATR buffer, appropriate for new capital
• RSI at 38 with price at extreme lower band extension creates real statistical possibility of 15-20% bounce before confirmation level
• Buyback halt is a yellow flag but not a smoking gun; company paid $2B in dividends last quarter and generated $8.9B in operating cash flow
• Dividend raised to $2.32/share demonstrates capital discipline, not distress
• 200 SMA at $344 remains intact, supporting long-term uptrend
• Aggressive analyst's $414.83 target close with positive MACD is a confirmation trigger for adding capital, not the only entry point
• MACD shows bearish crossover with widening negative histogram in confirmed downtrend
• Q3 earnings in mid-October represents binary catalyst requiring hedging via protective puts or collars rather than avoiding the position
• Defensive rotation theme is valid given 30-year yields at 19-year highs, but UNH carries idiosyncratic event risk making it a damaged defensive name
• Two separate stops for two separate decisions: existing position at $390, tactical add at $378-$380

→ vs aggressive: Coils release in both directions; MACD bearish crossover with widening negative histogram is not a coiled spring pointing up but market indecision; $390 stop for new capital is functionally no stop with ATR of $10.26, dressing up poor risk management as defined risk

→ vs aggressive: Forward P/E of 17.56 is fragile; if Q3 utilization re-accelerates and EPS gets cut, multiple expands to 22-23, eliminating the cheap valuation argument overnight

→ vs aggressive: Waiting for $414.83 close with positive MACD as the only entry point means buying at higher prices if the bounce materializes off the lower band, leaving significant returns on the table

→ vs conservative: If UNH bounces 15-20% off the lower band before confirming, waiting for $414.83 is leaving the table before dinner is served, not exercising patience

→ vs conservative: Buyback halt overstates the capital distress argument; $2B in dividends paid, $8.9B operating cash flow, and dividend hike to $2.32 show capital discipline, not distress

→ vs conservative: The conservative framing anchors on a specific capital action while ignoring the broader signal of dividend hikes and FCF resumption